Scott M Coiante insider trades

Open-market stock purchases and sales by Scott M Coiante, SVP, Chief Financial Officer at Lexicon Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 24, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -96%.

Recent trades

DateStockTradeValue
Feb 28, 2026LXRX Lexicon Pharmaceuticals, IncSold (not open market)$80.7K
Feb 28, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
Feb 12, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
Feb 12, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—

Companies traded

  • LXRX Lexicon Pharmaceuticals, Inc: other filings, last Feb 28, 2026
  • AGRX Agile Therapeutics Inc: other filings, last Aug 26, 2024
  • APRE Aprea Therapeutics, Inc: 1 buy, last Jul 28, 2022

Get free alerts when Scott M Coiante files a new trade →